Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
Clinical trial NCT04281108 · COMPLETED
Trial details
- NCT number
- NCT04281108
- Sponsor
- Ellodi Pharmaceuticals, LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-30
- Primary completion
- 2022-05-05
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.